Related Experiment Video
Updated: May 27, 2026

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
Published on: July 11, 2025
[Therapeutic management of malaria]
1Sektion Tropenmedizin/Infektiologie, I. Medizinische Klinik, Universitätsklinikum Hamburg-Eppendorf, Bernhard-Nocht-Strasse 74, Hamburg, Germany. gerd.burchard@bni-hamburg.de
Abstract:
Plasmodium falciparum and to some extent malaria caused by other species of Plasmodia can quickly lead to cerebral malaria, acute renal failure, or acute respiratory distress syndrome. The mortality rate for patients with severe malaria lies around 10%. Malaria must be given priority in the differential diagnosis of travelers returning febrile from endemic areas. Treatment requires prompt administration of safe and fast-acting antimalarials, which in severe malaria is treatment with quinine or artesunate. Hospitals must be prepared to diagnose and treat malaria patients-or have a standard operating procedure for transferring the patient to a specialized center.
More Related Videos
09:13Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
Published on: November 22, 2024
05:28Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
Published on: May 12, 2022
Related Concept Videos
Malaria
Anthelminthic Agents
Antiprotozoal Agents
Therapeutic Drug Monitoring: Affecting Factors
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Therapeutic Drug Monitoring: Overview and Classification